Abstract
Neurogenic lower urinary tract dysfunctions are common in patients with multiple sclerosis and for most of them urinary dysfunction has the most negative impact on their social life. No correlation exists between clinical urinary symptoms and urodynamic patterns. Abnormal urodynamic patterns may be present in asymptomatic patients. Both clinical and urodynamic findings may change during the course of the illness. Early diagnostic approach and scheduled follow-ups are mandatory in order to prevent upper urinary tract complications and improve quality of life (QoL).
Similar content being viewed by others
References
Litwiller SE, Frohman EM, Zimmern PE (1999) Multiple sclerosis and the urologist. J Urol 161:743–757
Hinson JL, Boone TB (1996) Urodynamics and multiple sclerosis. Urol Clin North Am 23:475–481
DasGupta R, Fowler CJ (2002) Sexual and urological dysfunction in multiple sclerosis: better understanding and improved therapies. Curr Opin Neurol 15:271–278
Wheeler JS, Siroky MB, Pavlakis AJ et al (1983) The changing neurourologic pattern of multiple sclerosis. J Urol 130:123
Bemelmans BL, Hommes OR, Van Kerrebroeck PE et al (1991) Evidence for early lower urinary tract dysfunction in clinically silent multiple sclerosis. J Urol 145:1219–1224
Rickwood AM (2002) Assessment and conservative management of the neuropathic bladder. Semin Pediatr Surg 11:108–119
Wyndaele JJ, Castro D, Madersbacher H et al (2005) Neurologic urinary and faecal incontinence. In: Abrams P, Cardozo L, Khoury S, Wein A (eds) Incontinence. Health Publications, Plymouth, 1061–1162
Wein AJ (1998) Pathophysiology and categorization of voiding dysfunction. In: Walsh PC, Retik AB, Vaughan Jr ED, Wein AJ (eds) Campbell’s urology, 7th Edn. WB Saunders, Philadelphia, 917–926
Krane RJ, Siroky MB (1979) Classification of neuro-urologic disorders. In: Krane RJ, Siroky MB (eds) Clinical neuro-urology. Little Brown, Boston, 143–158
Stöhrer M, Goepel M, Kondo A et al (1999) The standardization of terminology in neurogenic lower urinary tract dysfunction with suggestions for diagnostic procedures. International Continence Society Standardization Committee. Neurourol Urodyn 18:139–158
Weld KJ, Dmochowski RR (2000) Association of level of injury and bladder behavior in patients with posttraumatic spinal cord injury. Urology 55:490–494
Chancellor MB, Anderson RU, Boone TB (2006) Pharmacotherapy for neurogenic detrusor overactivity. Am J Phys Med Rehabil 85:536–545
Diokno A, Ingber M (2006) Oxybutynin in detrusor overactivity. Urol Clin N Am 33:439–445
Buyse G, Waldeck K, Verpoorten C et al (1998) Intravesical oxybutynin for neurogenic bladder dysfunction: less systemic side effects due to reduced first pass metabolism. J Urol 160:892–896
Di Stasi SM, Giannantoni A, Navarra P et al (2001) Intravesical oxybutynin: mode of action assessed by passive diffusion and electromotive administration with pharmacokinetics of oxybutynin and N-desethyl oxybutynin. J Urol 166:2232–2236
Christ KF, Kornhuber HH (1980) Treatment of neurogenic bladder dysfunction in multiple sclerosis by ultrasound-controlled bladder training. Arch Psychiatr Nervenkr 228:191–195
Yamanishi T, Yasuda K, Kamai T et al (2004) Combination of a cholinergic drug and an alpha-blocker is more effective than monotherapy for the treatment of voiding difficulty in patients with underactive detrusor. Int J Urol 11:88–96
De Ridder D, Vermeulen C, Ketelaer P et al (1999) Pelvic floor rehabilitation in multiple sclerosis. Acta Neurol Belg 99:61–64
Ishigooka M, Hashimoto T, Hayami S et al (1996) Electrical pelvic floor stimulation: a possible alternative treatment for reflex urinary incontinence in patients with spinal cord injury. Spinal Cord 34:411–415
McClurg D, Ashe RG, Marshall K, Lowe-Strong AS (2006) Comparison of pelvic floor muscle training, electromyography biofeedback, and neuromuscular electrical stimulation for bladder dysfunction in people with multiple sclerosis: a randomized pilot study. Neurourol Urodyn 25:337–348
Primus G, Kramer G (1996) Maximal external electrical stimulation for treatment of neurogenic or non neurogenic urgency and/or urge incontinence. Neurourol Urodyn 15:187–194
Amarenco G, Ismael SS, Even-Schneider A et al (2003) Urodynamic effect of acute transcutaneous posterior tibial nerve stimulation in overactive bladder. J Urol 169:2210–2215
Hagerty JA, Richards I, Kaplan WE (2007) Intravesical electrotherapy for neurogenic bladder dysfunction: a 22-year experience. J Urol 178:1680–1683
Del Popolo G, Filocamo MT, Li Marzi V et al (2007) Neurogenic detrusor overactivity treated with English botulinum toxin A: 8-year experience of one single centre. Eur Urol 53:1013–1019
Petit H, Wiart L, Gaujard E et al (1998) Botulinum: a toxin treatment for detrusor-sphincter dyssynergia in spinal cord disease. Spinal Cord 36:91–94
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Del Popolo, G., Panariello, G., Del Corso, F. et al. Diagnosis and therapy for neurogenic bladder dysfunctions in multiple sclerosis patients. Neurol Sci 29 (Suppl 4), 352–355 (2008). https://doi.org/10.1007/s10072-008-1042-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-008-1042-y